Gisborne’s Mātai Medical Research Institute has taken existing MRI research to a new level using ultra-high contrast MRI ...

Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...

Levels of iron in the brain could be a warning sign of future Alzheimer’s disease, a new study suggests. High levels of the chemical element have been shown to increase brain toxins and trigger ...

Gadopiclenol only requires half of the gadolinium dose of conventional nonspecific GBCAs. Elucirem ™ (gadopiclenol) and Vueway ™ (gadopiclenol) are now available for use with magnetic resonance ...

OHSU lab started exploring new use of the drug 30 years ago; now, it may improve techniques to measure, monitor aggressive ...

Envisioning pathological processes in the central nervous system using preclinical MRI Magnetic resonance imaging (MRI) is a well-known means of imaging for clinically managing patients with ...

Italy-based Bracco Imaging and Subtle Medical have obtained an EU CE mark for AiMIFY, a jointly developed software designed to enhance the imaging of contrast MRI brain scans using artificial ...

For almost three decades, functional magnetic resonance imaging (fMRI) has been one of the main tools in brain research. Yet a new study published in Nature Neuroscience fundamentally challenges the ...

The volume of contrast media used for diagnostic imaging, including iodinated and gadolinium agents, has increased in recent years.

The brain MRI is important for the diagnosis of prion disease for ruling out other possible etiologies, but it can also show features suggestive of prion disease. Brain MRI findings are found in most ...